SZSE:002550 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SZSE:002550 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Changzhou Qianhong Biopharma Co's cash flow for dividends for the three months ended in Sep. 2024 was ¥-0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-152 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
Changzhou Qianhong Biopharma Co's quarterly payment of dividends increased from Mar. 2024 (¥-0 Mil) to Jun. 2024 (¥-151 Mil) but then declined from Jun. 2024 (¥-151 Mil) to Sep. 2024 (¥-0 Mil).
Changzhou Qianhong Biopharma Co's annual payment of dividends increased from Dec. 2021 (¥-152 Mil) to Dec. 2022 (¥-155 Mil) and increased from Dec. 2022 (¥-155 Mil) to Dec. 2023 (¥-159 Mil).
The historical data trend for Changzhou Qianhong Biopharma Co's Cash Flow for Dividends can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Changzhou Qianhong Biopharma Co Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Cash Flow for Dividends | Get a 7-Day Free Trial | -170.14 | -313.62 | -151.51 | -155.16 | -158.79 |
Changzhou Qianhong Biopharma Co Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Cash Flow for Dividends | Get a 7-Day Free Trial | -2.29 | -0.07 | -0.20 | -151.46 | -0.19 |
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-152 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Changzhou Qianhong Biopharma Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.
Huang Jie | Executives | |
Wang Ke | Directors, executives | |
Jiang Wen Qun | Supervisors | |
Zou Shao Bo | Executives | |
Wei Li Jun | Executives | |
Mei Chun Wei | Executives | |
Zhou Xiang | Directors, executives | |
Zhao Gang | Director | |
Ye Hong Ping | Executives | |
Liu Jun | Director | |
Fan Yong | Executives | |
Jiang Jian Ping | Supervisors | |
Wang Yao Fang | Director | |
Hai Tao | Directors, executives | |
Wang Yi | Director |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.